Simponi 50 MG/0.5 ML pen injec 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FP3NF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,152
Award facts
- Contract value 100% obligated
- $19,151.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,151.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SIMPONI 50 mg/0.5 mL pen injections on September 17, 2025, with an ultimate completion date of September 18, 2025. This delivery order, which carries no set-aside designation, represents a competitively awarded procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for military and veteran healthcare systems. The company's place of performance is listed as its corporate office location in Conshohocken, PA 19428.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. SIMPONI (golimumab), a biologic immunosuppressive agent used primarily for rheumatoid arthritis and other inflammatory conditions, represents the type of specialty pharmaceutical product that AmerisourceBergen Drug Corp delivers through its DLA contracts to support the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FP3NF?
SPE2DB25FP3NF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FP3NF worth?
The government has obligated $19,152 on SPE2DB25FP3NF.
Is contract SPE2DB25FP3NF an order under another contract?
Yes. SPE2DB25FP3NF is a delivery order under SPE2DB22D3010, an indefinite delivery contract.
Was contract SPE2DB25FP3NF competed?
The extent of competition for SPE2DB25FP3NF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award